Gene · 7913
Papers1,526
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,526
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody. | Front Immunol | 2022 | 36119088 | PubTator, text mining | PubMed |
| miR-181-5p attenuates neutrophilic inflammation in asthma by targeting DEK. | Int Immunopharmacol | 2022 | 36115279 | PubTator, text mining | PubMed |
| IMMUNOEXPRESSION OF DEK AND PHOSPHO-P38 PROTEINS IN RECTAL CANCER BEFORE CHEMORADIATION THERAPY. | Arq Gastroenterol | 2022 | 36102441 | PubTator, text mining | PubMed |
| The in vivo Interaction Landscape of Histones H3.1 and H3.3. | Mol Cell Proteomics | 2022 | 36089195 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Serum Small Extracellular Vesicles-Derived Coding and Non-Coding RNAs from Retinoblastoma Patients for Identifying Regulatory Interactions. | Cancers (Basel) | 2022 | 36077715 | PubTator, text mining | PubMed |
| PARP1: Liaison of Chromatin Remodeling and Transcription. | Cancers (Basel) | 2022 | 36077699 | PubTator, text mining | PubMed |
| NMR-based metabolomic analysis identifies RON-DEK-β-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival. | PLoS One | 2022 | 36067206 | PubTator, text mining | PubMed |
| Identification and Validation in a Novel Classification of Helicase Patterns for the Prediction of Tumor Proliferation and Prognosis. | J Hepatocell Carcinoma | 2022 | 36061235 | PubTator, text mining | PubMed |
| Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy. | Nat Commun | 2022 | 36057605 | PubTator, text mining | PubMed |
| Promising Strategies for Transdermal Delivery of Arthritis Drugs: Microneedle Systems. | Pharmaceutics | 2022 | 36015362 | PubTator, text mining | PubMed |
Identification of Leukemia-Associated Immunophenotypes by Databaseguided Flow Cytometry Provides a Highly Sensitive and Reproducible Strategy for the Study of Measurable Residual Disease in Acute Myeloblastic Leukemia. | Cancers (Basel) | 2022 | 36011002 | PubTator, text mining | PubMed |
| SV40 miR-S1 and Cellular miR-1266 Sequester Each Other from Their Targets, Enhancing Telomerase Activity and Viral Replication. | Noncoding RNA | 2022 | 36005825 | PubTator, text mining | PubMed |
| CD163 Immunohistochemical "Circle Sign" Staining Pattern Differentiates Sinonasal Papillomas From Morphologically Similar Non-neoplastic Lesions. | Am J Surg Pathol | 2022 | 35993580 | PubTator, text mining | PubMed |
| Fisetin induces DNA double-strand break and interferes with the repair of radiation-induced damage to radiosensitize triple negative breast cancer cells. | J Exp Clin Cancer Res | 2022 | 35989353 | PubTator, text mining | PubMed |
| Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling. | Nat Commun | 2022 | 35987950 | PubTator, text mining | PubMed |
| Virus-host interaction analysis in colorectal cancer identifies core virus network signature and small molecules. | Comput Struct Biotechnol J | 2022 | 35983230 | PubTator, text mining | PubMed |
| In silico gene expression and pathway analysis of DEK in the human brain across the lifespan. | Eur J Neurosci | 2022 | 35972263 | PubTator, text mining | PubMed |
| Development of novel gene signatures for the risk stratification of prognosis and diagnostic prediction of osteosarcoma patients using bioinformatics analysis. | Transl Cancer Res | 2022 | 35966307 | PubTator, text mining | PubMed |
| Post-Transplant Cyclophosphamide after Matched Sibling and Unrelated Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia. | Int J Mol Sci | 2022 | 35955881 | PubTator, text mining | PubMed |
| The Protective Action of Metformin against Pro-Inflammatory Cytokine-Induced Human Islet Cell Damage and the Mechanisms Involved. | Cells | 2022 | 35954309 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7913/papers?page=13